Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy von Vollebergh, Marieke A, Lips, Esther H, Nederlof, Petra M, Wessels, Lodewyk F A, Wesseling, Jelle, Vd Vijver, Marc J, de Vries, Elisabeth G E, van Tinteren, Harm, Jonkers, Jos, Hauptmann, Michael, Rodenhuis, Sjoerd, Linn, Sabine C

Volltext

Towards Personalization in the Curative Treatment of Gastric Cancer von Slagter, Astrid E, Vollebergh, Marieke A, Jansen, Edwin P M, van Sandick, Johanna W, Cats, Annemieke, van Grieken, Nicole C T, Verheij, Marcel

Volltext

Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness von Lips, Esther H, Laddach, Nadja, Savola, Suvi P, Vollebergh, Marieke A, Oonk, Anne M M, Imholz, Alex L T, Wessels, Lodewyk F A, Wesseling, Jelle, Nederlof, Petra M, Rodenhuis, Sjoerd

Volltext

Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases von Vollebergh, Marieke A, Klijn, Christiaan, Schouten, Philip C, Wesseling, Jelle, Israeli, Danielle, Ylstra, Bauke, Wessels, Lodewyk F A, Jonkers, Jos, Linn, Sabine C

Volltext

Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial von Verschoor, Yara L., van de Haar, Joris, van den Berg, José G., van Sandick, Johanna W., Kodach, Liudmila L., van Dieren, Jolanda M., Balduzzi, Sara, Grootscholten, Cecile, IJsselsteijn, Marieke E., Veenhof, Alexander A. F. A., Hartemink, Koen J., Vollebergh, Marieke A., Jurdi, Adham, Sharma, Shruti, Spickard, Erik, Owers, Emilia C., Bartels-Rutten, Annemarieke, den Hartog, Peggy, de Miranda, Noel F. C. C., van Leerdam, Monique E., Haanen, John B. A. G., Schumacher, Ton N., Voest, Emile E., Chalabi, Myriam

Volltext

High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer von Schouten, Philip C, Vollebergh, Marieke A, Opdam, Mark, Jonkers, Martijn, Loden, Martin, Wesseling, Jelle, Hauptmann, Michael, Linn, Sabine C

Volltext

Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers von Vollebergh, Marieke A., Jonkers, Jos, Linn, Sabine C.

Volltext

Tumor-positive peritoneal cytology in patients with gastric cancer is associated with poor outcome: A nationwide study von Van Der Sluis, Karen, Taylor, Steven N., Kodach, Liudmila L., van Dieren, Jolanda M., de Hingh, Ignace H.J.T., Wijnhoven, Bas P.L., Verhoeven, Rob H.A., Vollebergh, Marieke A., van Sandick, Johanna W.

Volltext

Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial von Verschoor, Yara L., van de Haar, Joris, van den Berg, José G., van Sandick, Johanna W., Kodach, Liudmila L., van Dieren, Jolanda M., Balduzzi, Sara, Grootscholten, Cecile, IJsselsteijn, Marieke E., Veenhof, Alexander A. F. A., Hartemink, Koen J., Vollebergh, Marieke A., Jurdi, Adham, Sharma, Shruti, Spickard, Erik, Owers, Emilia C., Bartels-Rutten, Annemarieke, den Hartog, Peggy, de Miranda, Noel F. C. C., van Leerdam, Monique E., Haanen, John B. A. G., Schumacher, Ton N., Voest, Emile E., Chalabi, Myriam

Volltext

Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid von van der Sluis, Karen, van Sandick, Johanna W., Vollebergh, Marieke A., van Dieren, Jolanda M., Hugen, Niek, Hartemink, Koen J., Veenhof, Alexander A. F. A., Verhoeven, Els, van den Berg, José G., Snaebjornsson, Petur, Noe, Michael, van Wezel, Tom, Boelens, Mirjam C., Kodach, Liudmila L.

Volltext

Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [18F]FDG PET/CT: a systematic review and individual patient data meta-analysis von Willemse, Jeroen R. J., Lambregts, Doenja M. J., Balduzzi, Sara, Schats, Winnie, Snaebjornsson, Petur, Marchetti, Serena, Vollebergh, Marieke A., van Golen, Larissa W., Cheung, Zing, Vogel, Wouter V., Bodalal, Zuhir, Rostami, Sajjad, Gerke, Oke, Sivakumaran, Tharani, Beets-Tan, Regina G.H., Lahaye, Max J.

Volltext

The clinical impact of testing for biomarkers in gastric cancer patients: a real‐world cohort von Sluis, Karen, Sandick, Johanna W, Dieren, Jolanda M, Vollebergh, Marieke A, Grootscholten, Cecile, Berg, José G, Snaebjornsson, Petur, Hartemink, Koen J, Veenhof, Alexander A F A, Chalabi, Myriam, Kodach, Liudmila L

Volltext

Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial von Slagter, Astrid E., Vollebergh, Marieke A., Caspers, Irene A., van Sandick, Johanna W., Sikorska, Karolina, Lind, Pehr, Nordsmark, Marianne, Putter, Hein, Braak, Jeffrey P. B. M., Meershoek-Klein Kranenbarg, Elma, van de Velde, Cornelis J. H., Jansen, Edwin P. M., Cats, Annemieke, van Laarhoven, Hanneke W. M., van Grieken, Nicole C. T., Verheij, Marcel

Volltext

Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal Carcinomatosis von Verbeek, Joost G. E., van der Sluis, Karen, Vollebergh, Marieke A., van Sandick, Johanna W., van Harten, Wim H., Retèl, Valesca P.

Volltext

Impact of Intertumoral Heterogeneity on Predicting Chemotherapy Response of BRCA1-Deficient Mammary Tumors von ROTTENBERG, Sven, VOLLEBERGH, Marieke A, LODEN, Martin, SOL, Wendy, DER BURG, Eline Van, WESSELING, Jelle, GILLET, Jean-Pierre, GOTTESMAN, Michael M, GRIBNAU, Joost, WESSELS, Lodewyk, LINN, Sabine C, JONKERS, Jos, DE HOON, Bas, BORST, Piet, DE RONDE, Jorma, SCHOUTEN, Philip C, KERSBERGEN, Ariena, ZANDER, SergeA. L, PAJIC, Marina, JASPERS, Janneke E, JONKERS, Martijn

Volltext

IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 muta... von Rozeman, Elisa A, Versluis, Judith M, Sikorska, Karolina, Hoefsmit, Esmée P, Dimitriadis, Petros, Rao, Disha, Lacroix, Ruben, Grijpink-Ongering, Lindsay G, Lopez-Yurda, Marta, Heeres, Birthe C, van de Wiel, Bart A, Flohil, Claudie, Sari, Aysegul, Heijmink, Stijn W T P J, van den Broek, Daan, Broeks, Annegien, de Groot, Jan Willem B, Vollebergh, Marieke A, Wilgenhof, Sofie, van Thienen, Johannes V, Haanen, John B A G, Blank, Christian U

Volltext

Ligands of Epidermal Growth Factor Receptor and the Insulin-Like Growth Factor Family as Serum Biomarkers for Response to Epidermal Growth Factor Receptor Inhibitors in Patients wi... von Vollebergh, Marieke A., Kappers, Ingrid, Klomp, Houke M., Buning-Kager, Johanna C., Korse, Catharina M., Hauptmann, Michael, de Visser, Karin E., van den Heuvel, Michel M., Linn, Sabine C.

Volltext

Identifying the primary tumour in patients with cancer of unknown primary (CUP) using 18FFDG PET/CT: a systematic review and individual patient data meta-analysis von Willemse, Jeroen R J, Lambregts, Doenja M J, Balduzzi, Sara, Schats, Winnie, Snaebjornsson, Petur, Marchetti, Serena, Vollebergh, Marieke A, van Golen, Larissa W, Cheung, Zing, Vogel, Wouter V, Bodalal, Zuhir, Rostami, Sajjad, Gerke, Oke, Sivakumaran, Tharani, Beets-Tan, Regina G H, Lahaye, Max J

Volltext

IMPemBra, a phase 2 study comparing pembrolizumab with intermittent/short‐term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 muta... von Rozeman, Elisa A., Versluis, Judith M., Hoefsmit, Esmée P, Dimitriadis, Petros, Grijpink-Ongering, Lindsay G., Sikorska, Karolina, van de Wiel, Bart A., Heeres, Birthe C, Flohil, Claudi, Kvistborg, Pia, van den Broek, Daan, Broeks, Annegien, de Groot, Jan Willem, Wilgenhof, Sofie, Vollebergh, Marieke A., van Thienen, Johannes V., Haanen, John B. A. G., Blank, Christian U.

Volltext

Neoadjuvant atezolizumab plus docetaxel/oxaliplatin/capecitabine in non-metastatic gastric and gastroesophageal junction adenocarcinoma: The PANDA trial von Verschoor, Yara L., Kodach, Liudmila, van den Berg, José, van Sandick, Johanna W., van Dieren, Jolanda, Balduzzi, Sara, Grootscholten, Cecile, Veenhof, Xander, Hartemink, Koen, Vollebergh, Marieke A., Owers, E.C., Bartels-Rutten, Annemarieke, den Hartog, Peggy, van Leerdam, Monique E, Schumacher, Ton, Voest, Emile E., Haanen, John B. A. G., Chalabi, Myriam

Volltext